Ruijin Neurobank of Alzheimer's Disease and Dementia

Recruiting now

Conditions studied: Dementia

In brief

The goal of this observational study is to learn about neuroimage and biomarkers in the Alzheimer's continuum. The main questions it aims to answer are: * How is the neurovascular coupling during AD pathogenesis? * How is the pattern/mapping of alterations in AD biomarkers? Participants will be observed and visit the research center annually to perform multi-modal MRI, PET, neuropsychological tests, and blood tests.

Key facts

Study ID: NCT05623124
Run by: Ruijin Hospital
People needed: 400
Starts: 2021-11-22
Expected to finish: 2025-10-01
Last updated by the study team: 2024-11-25

Who can join

Age: 50 and older, up to 90. Sex: any. Healthy volunteers: accepted.

You may qualify if…

Male and female aged 50 to 90 years old;
In accordance with the diagnostic criteria for "mild cognitive impairment due to Alzheimer's disease" and "Dementia" from the National Institutes of Health National Institute on Aging-Alzheimer's Association (NIA-AA) (2011);
The Hamilton depression rating scale/17 edition (HAMD) total score<10;
The clinical dementia rating (CDR) is 0.5 or above;
Neurological examination: no obvious signs;
Participants should have a caregiver stable and reliable.
Education: primary school (grade 6) or above. They have the ability to complete tests for cognitive ability and have the ability and time to complete regulation of cognitive training

You may not qualify if…

Other causes of cognitive decline: cerebrovascular disease, central nervous system infection, CJD, Huntington's and Parkinson's disease, DLB, traumatic brain dementia, other physical and chemical factors (such as drugs, alcohol, CO), systemic disease (hepatic encephalopathy, pulmonary encephalopathy, etc.), intracranial occupation (a subdural hematoma, brain tumor), the endocrine system disease (thyroid disease, parathyroid disease), and vitamins deficiency or any other causes of dementia.
The history of nervous system diseases, including stroke, optic myelitis, Parkinson's disease, epilepsy, etc.);
Psychiatric patients, including schizophrenia or other mental illnesses, bipolar disorder, major depression, or delirium;
There are unstable or serious heart, lung, liver, kidney, and hematopoietic system diseases; Poor prognosis because of malignant diseases such as tumors.
Vision or hearing problems that lead to poor performance on cognitive tests;
Two years history of severe alcoholism, and drug abuse;
The researchers believe that the subjects could not complete the study.
Contraindication of MRI or PET scanning.

Where it is running

Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine — Shanghai, Shanghai Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.